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Abstract
In both humans and laboratory animals, the reports of cognitive eﬀects following acute amphetamine
(Amph) administration are mixed and depend, for example, on the timing of administration (e.g. before or
after task acquisition) and/or on the memory model used. Besides its cognitive eﬀects, Amph produces
other important behavioural eﬀects, including alterations in anxiety and general activity, which could
modify the subject’s internal state, thereby facilitating state-dependent learning. Importantly, state-
dependency has been linked to drug dependence in humans. This study evaluates the role of state-
dependent learning in Amph-induced memory deﬁcits in mice submitted to a discriminative avoidance
task. Mice were given Amph (3 mg/kg) before training and/or before testing in the plus-maze
discriminative avoidance task, an animal model that concomitantly evaluates learning, memory, anxiety-
like behaviour and general activity. Pre-training Amph administration did not aﬀect the ability to learn the
discriminative task, but rather induced anxiogenic-like eﬀects and a marked retention deﬁcit in the test
session. This memory impairment was completely absent when animals received Amph before both the
training and the test sessions. Amph-induced memory impairment of a discriminative avoidance task is
state-dependent, such that a response acquired in the ‘Amph state’ cannot be recalled in the normal state.
The involvement of anxiety alterations in this ‘Amph state’ is discussed.
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Introduction
Amphetamine (Amph) is highly addictive and can
cause individuals to exhibit eﬀects ranging from rela-
tively minor cognitive impairment to severe psychotic
symptoms (Wood & Anagnostaras, 2009). In clinical
practice, Amph is used in the treatment of attention-
deﬁcit hyperactivity disorder as well as excessive
daytime sleepiness and narcolepsy (Ahmann et al.
2001). However, its indiscriminate usage is a growing
social problem, as Amph has been regarded by
the public to be a cognitive enhancer, presumably
by promoting mental arousal or wakefulness (Butcher,
2003).
With regard to the acute eﬀects of Amph on
the cognitive processes of learning and memory,
reports have been mixed and include an absence of
eﬀects (Beuzen et al. 1994), memory enhancement
(Roozendaal et al. 1996; Ventulani et al. 1993) and
memory deﬁcits (Ornstein et al. 2000; Silva et al. 2002a).
The nature of the eﬀect seems to depend on several
factors, including the timing of administration (e.g.
before or after task acquisition) and whether the study
uses humans (Soetens et al. 1995) or laboratory animals
(Simon & Setlow, 2006 ; Wood & Anagnostaras, 2009)
as well as the memory model.
Previous studies have shown that Amph promotes
memory improvement principally when given post-
acquisition, supporting the idea that its eﬀects
are speciﬁcally related to memory consolidation. In
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pre-clinical studies, systemic post-training injections
of Amph have been shown to enhance the consoli-
dation of spatial learning (Brown et al. 2000; Packard &
White, 1989), active avoidance and appetitive (Janak &
Martinez, 1992) conditioning tasks (Simon & Setlow,
2006). However, when given pre-training, Amph-
induced eﬀects on memory are highly contradictory
and include both facilitatory (Beuzen et al. 1994;
Ventulani et al. 1993) and inhibitory (Silva et al. 2002a ;
Wood & Anagnostaras, 2009) eﬀects. The inhibitory
pre-training eﬀects of this drug on memory perform-
ance can be critically modiﬁed by Amph-induced
learning impairment and/or the involvement of
the state-dependency phenomenon (i.e. the retrieval
of a memory engram may require the organism to be
in a state that is similar to that in which the engram
was initially acquired ; Bruins Slot & Colpaert, 1999).
Regarding state-dependency, Amph produces im-
portant behavioural eﬀects on both emotional levels
(Lin et al. 1999) and general activity (Bernardi et al.
1986; Fukushiro et al. 2007), which could modify the
organism’s internal state, thereby facilitating state-
dependent learning. From a clinical perspective, this
state-dependency could play an important role in
Amph abuse, as cues (such as drug intake context
and drug-induced interoceptive eﬀects) can become
associated with the reinforcement properties of the
drug itself (Alvarez et al. 2006; Simon & Setlow, 2006).
In a previous study (Silva et al. 2002a), we in-
vestigated the eﬀects of Amph on the plus-maze dis-
criminative avoidance task (PM-DAT), an animal
model that evaluated learning, memory, anxiety and
general activity concomitantly (Gulick & Gould, 2011;
Silva & Frussa-Filho, 2000). We demonstrated that
when 3 mg/kg Amph was given acutely before train-
ing, it signiﬁcantly decreased anxiety and impaired
memory in the test session. When the drug was ad-
ministered acutely after the training session, no cog-
nitive eﬀects were found. After repeated treatment
(daily injections for 10 d), the anxiogenic eﬀect was
abolished while the amnestic eﬀect remained. In order
to extend these ﬁndings, the aim of the present study
was to investigate the role of state-dependency on
the eﬀects of the same pre-training amnestic dose of
Amph (3 mg/kg; Silva et al. 2002a) in mice subjected
to the PM-DAT.
Methods
Subjects
Swiss EPM-M1 male mice (aged 3 months ; outbred,
raised and maintained in the Centre for Development
of Experimental Models in Medicine and Biology of
Universidade Federal de Sa˜o Paulo) were used.
Animals weighing 30–35 g were housed under con-
trolled temperatures (22–23 xC) and lighting (12-h
light/dark cycle, lights on 06:45 hours). Food and
water were available ad libitum. Animals used in this
study were maintained in accordance with the
National Institute of Health Guide for the care and use
of laboratory animals (NIH Publications No. 80-23),
revised 1996 and the Brazilian Law for Procedures for
Animal Scientiﬁc Use (#11794/2008). The experimen-
tal procedures were approved by the Institutional
Animal Care and Use Committee under the protocol
#0960/09.
Drugs
D-amphetamine sulfate (3 mg Amph/kg body weight ;
Sigma Chemical Co., USA) was diluted in saline (Sal)
to a total volume of 10 ml/kg and was injected i.p. For
control mice, Sal was injected.
PM-DAT
The apparatus employed in the PM-DAT was a
modiﬁed wooden elevated plus-maze containing
two enclosed arms with sidewalls and no top
(lengthrwidthrheight=28.5r7r18.5 cm) opposite
from two open arms (lengthrwidth=28.5r7 cm).
The aversive enclosed arm was an enclosed arm with
a 100-W lamp (which was turned on only during the
aversive stimulus) placed over the exact centre and a
sound generator placed under the arm. In the 10-min
training session, the mouse was placed at the
centre of the apparatus ; when the animal entered the
aversive enclosed arm, continuous aversive stimuli
were delivered and were continued until the animal
left the arm. The aversive stimuli consisted of both
illuminating the 100-W light and generating an 80-dB
sound. In the test session (performed in the same room
24 h after the training session), the mouse was again
placed in the centre of the apparatus and was ob-
served for 3 min. However, no aversive stimuli were
applied when the mouse entered the aversive enclosed
arm (although the non-illuminated lamp remained in
the middle of this arm to provide a visual spatial cue
for identifying the aversive arm).
It is important to mention that the duration of the
training session was 10 min while the duration of
the test session was only 3 min. In fact the test session
was shorter to avoid the possibility that animals re-
interpreted the aversively enclosed arm as a neutral/
safe place in the testing (when the aversive stimuli is
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absent), preventing the inﬂuence of a new learning
that would impair the measurement of memory in the
test session.
During both sessions, the experimenter was blind to
the mouse’s treatment group, and the apparatus was
cleaned with 5% alcohol after each session. The time
spent in each arm of the apparatus (aversive, non-
aversive and open arms) as well as numbers of entries
(an entry is deﬁned as the placement of all four paws
in one arm) in each of these arms was recorded. Based
on them, we calculated the total number of entries into
any of the arms; percent time spent in the aversive
enclosed arm (time spent in aversive enclosed arm/
time spent in both the enclosed armsr100) and per-
cent time spent in the open arms (time spent in open
arms/sum of the time spent in both open and both the
enclosed armsr100).
In the present study, we considered the following:
$ Learning: the progressive avoidance to the aversive
enclosed arm represented by the decrease in percent
time spent in the aversive enclosed arm throughout
the training session, when the aversive stimuli are
present.
$ Memory: the discrimination of the time spent
in the aversive vs. non-aversive enclosed arms
during the test session. Among the groups, the
percent time spent in the aversive enclosed arm,
which represents retention of the task in the test
session, was compared to test for quantitative dif-
ferences.
$ Anxiety : the percent time spent in the open arms of
the apparatus.
$ Locomotion : number of entries into any of the arms.
Statistical analysis
The total number of entries into any arm, the percent
time spent in the open arms and the percent time spent
in the aversive enclosed arm were calculated and
compared using the t test for independent samples in
the training session and two-way analysis of variance
(ANOVA) followed by Duncan’s test in the testing
session. The ANOVA with repeated measures was
employed to analyse the decrease in percent time
spent in the aversive enclosed arm throughout the
training and test sessions. Two-way ANOVA followed
by Duncan’s test was used to analyse the time spent in
the aversive vs. non-aversive enclosed arms during the
training session and three-way ANOVA was used in
the test session to analyse the same parameter. A
probability of p<0.05 was considered signiﬁcant for
all comparisons made.
Experimental design
Role of state-dependency in memory impairment induced
by acute administration of Amph in mice tested in the
PM-DAT
Mice were randomly assigned to one of four exper-
imental groups containing 10 mice each. The groups
were based on whether they were to receive either Sal
or Amph (3 mg/kg body weight) before the training
and/or test session: pre-training/pre-test injection of
Sal (Sal–Sal) ; pre-test injection of Amph (Sal–Amph) ;
pre-training administration of Amph (Amph–Sal) ;
or pre-training/pre-test administration of Amph
(Amph–Amph). The animals were subjected to a
training session in the PM-DAT 15 min after the rel-
evant injection and the behavioural parameters de-
scribed above were registered minute by minute. The
mice received their second injection of Sal or Amph
24 h after the training session and a test session was
performed 15 min later.
Results
Role of state-dependency in memory impairment
induced by acute administration of Amph in mice
tested in the PM-DAT
The Sal–Sal and Sal–Amph groups performed the
training session after a Sal injection, whereas the
Amph–Sal and Amph–Amph groups performed this
session after an Amph injection. Therefore, for the
training session, data from animals of the Sal–Sal and
Sal–Amph groups were pooled into the Sal group;
similarly, training session data from the Amph–Sal
and Amph–Amph groups were pooled into the Amph
group. Two-way ANOVA for time spent in both en-
closed arms revealed that only the arm type factor
(aversive vs. non-aversive) had a signiﬁcant eﬀect
(F1,76=496.35 ; p<0.001). No signiﬁcant eﬀects of
treatment factor (SalrAmph; F1,76=0.56 ; p=0.45) or
interaction (F1,76=0.73 ; p=0.39) were found. The post-
hoc analysis by Duncan’s test revealed that the mice
treated with either Sal or Amph spent signiﬁcantly less
time in the aversive arm than in the non-aversive en-
closed arm during the training session (Fig. 1a), con-
ﬁrming the eﬀectiveness of the aversive stimuli. The t
test for independent samples showed no signiﬁcant
diﬀerence between groups concerning the percent
time spent in the aversive enclosed arm in the train-
ing session as a whole (t38=0.92 ; p=0.36 ; Fig. 1b).
ANOVA for the percent time spent in the aversive
arm with treatment as the between-subject factor and
time (minutes of observation) as the repeated-measure
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factor revealed a signiﬁcant eﬀect of time (F9,342=
11.21 ; p<0.001). Importantly, the percent time spent in
the aversive arm was decreased by the same magni-
tude in both groups, demonstrating a similar rate
for learning the task (Fig. 1c).
In the test session, three-way ANOVA with pre-
training (SalrAmph) and pre-test (SalrAmph) treat-
ments as between-subject factors and arm type as
the within-subject factor was applied. The analysis
revealed a signiﬁcant eﬀect of arm type (F1,72=700.48 ;
p<0.001), as well as signiﬁcant pre-training treat-
mentrarm type (F1,72=11.04 ; p=0.001), pre-test
treatmentrarm type (F1,72=34.42 ; p<0.001) and pre-
trainingrpre-testrarm type (F1,72=12.63 ; p=0.001)
interaction eﬀects. On the other hand, no signiﬁcant
eﬀects were found for pre-training (F1,72=0.001;
p=0.98) or pre-test (F1,72=2.73 ; p=0.10) factors. The
post-hoc analysis by Duncan’s test revealed that ani-
mals from all four experimental groups spent signiﬁ-
cantly less time in the aversive enclosed arm than in
the non-aversive enclosed arm (Fig. 2a). Since all
mice retained the task, the percent time spent in the
aversive enclosed arm was analysed to explore poss-
ible diﬀerences in the magnitude of this retention.
Accordingly, two-way ANOVA followed by Duncan’s
test revealed signiﬁcant eﬀects of pre-training
(F1,36=5.10 ; p<0.05) and pre-test (F1,36=9.88 ;
p<0.005) treatments and pre-trainingrpre-test inter-
action (F1,36=5.06 ; p<0.05). This ﬁnding shows that
this parameter (i.e. memory impairment) was en-
hanced in the animals treated with Amph before
training (Amph-Sal) relative to the other three groups.
Taken together, these data demonstrate that pre-
training Amph treatment causes state-dependent
memory impairment, inasmuch as the pre-test ad-
ministration of this drug (Amph–Amph) abolishes
such memory deﬁcit (Fig. 2b).
The ANOVA for the percent time spent in the
aversive arm with treatment as the between-subject
factor and time as the repeated-measure factor re-
vealed only signiﬁcant eﬀect of pre-test factor
(F1,36=4.50 ; p=0.04) and pre-trainingrpre-test
(F1,36=6.17 ; p=0.02) interaction. No signiﬁcant
eﬀects were found for time (F2,72=0.40 ; p=0.67),
timerpre-training (F2,72=0.09 ; p=0.92), timerpre-
test (F2,72=0.38 ; p=0.69), timerpre-trainingrpre-test
(F2,72=0.08 ; p=0.92) or pre-training (F1,36=1.39 ;
p=0.25). Indeed, all groups displayed a linear percent
time spent in the aversive arm throughout the session,
demonstrating that the cognitive eﬀects are related to
drug-induced impairment and not to a possible new
learning that the aversive is no longer threatening
(Fig. 2c).
Concerning anxiety-like behaviour and locomotor
activity, with regard to the percent time spent in the
open arms during the training session, t test for inde-
pendent samples revealed that the animals treated
with Amph spent signiﬁcantly less time in these arms,
consistent with an anxiogenic eﬀect (t38=2.11 ; p<0.05 ;
Fig. 3a). Conversely, no signiﬁcant diﬀerence was
found when the total number of entries was analysed
(t38=0.24 ; p=0.81 ; Fig. 3b).
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Fig. 1. The eﬀect of acute amphetamine (Amph) on the
training performance of mice in the plus-maze discriminative
avoidance task. Mice were treated with saline (Sal) or
3 mg/kgAmph 15 min before the training session. Results are
presented as means¡S.E. of time (s) spent in the non-aversive
and aversive enclosed arms (a), percent time spent in the
aversive enclosed arm in the session as awhole (b) and percent
time spent in the aversive enclosed arm minute-by-minute
throughout the training session (c). a p<0.05 compared to the
time spent in the non-aversive enclosed armwithin the group;
b p<0.05 compared to the time spent in the non-aversive
enclosed arm of the other group (two-way analysis of variance
and Duncan’s test).
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With regard to the percent time spent in the
open arms during the test session, two-way ANOVA
revealed no signiﬁcant eﬀects of pre-training
(F1,36=0.37 ; p=0.55), pre-test (F1,36=2.46 ; p=0.13) or
pre-trainingrpre-test (F1,36=0.00 ; p=0.99 ; Fig. 3c).
Finally, two-way ANOVA for the total number of
entries showed signiﬁcant eﬀects of pre-test
treatment (F1,36=7.56 ; p=0.009), but not for pre-
training (F1,36=0.41 ; p=0.52) or pre-trainingrpre-test
(F1,36=0.09 ; p=0.77). Hence, the mice injected with
Amph prior to the test session (the Sal–Amph and
Amph–Amph groups) exhibited decreased motor ac-
tivity compared to their respective control groups that
were treated with Sal (Sal–Sal and Amph–Sal ; Fig. 3d).
Discussion
Whereas there are many reports describing the eﬀect
of post-training Amph administration in facilitating
memory tasks (Packard & White, 1989 ; Simon &
Setlow, 2006), the pre-training eﬀects of this psycho-
stimulant on memory are highly controversial
(Ventulani et al. 1993; Wood & Anagnostaras, 2009).
Thus, although Amph seems to improve memory
consolidation, pre-training administration can impair
cognitive performance by either inhibiting the learn-
ing process or producing state-dependent memory
deﬁcits. Using the PM-DAT, we found that pre-
training Amph administration produced memory
deﬁcits in the absence of a learning impairment.
However, these deﬁcits were completely abolished
by a subsequent pre-test Amph injection, revealing a
critical role of state-dependency in the cognitive eﬀects
of Amph.
In the PM-DAT, learning is deﬁned as progressively
decreased exploration of the aversive enclosed arm
where light and sound (the aversive stimuli) are pre-
sented during the training session. Since learning is
quantiﬁed as a change in performance within a
speciﬁc period of time, the progressive learned
avoidance of this arm is measured as the percent time
spent in the arm throughout the training session
(Alvarenga et al. 2008; Niigaki et al. 2010; Patti et al.
2006). With regard to the experimental validation of
this parameter as a learning index, we have demon-
strated that, for example, sleep deprivation produces
learning deﬁcits in rats (Alvarenga et al. 2008), which is
in agreement with clinical data (Dinges et al. 1997). In
the present study, the pre-training acute adminis-
tration of Amph did not alter the animals’ ability to
progressively avoid the aversive enclosed arm in the
training session, suggesting that learning remained
intact (Fig. 1c). In contrast, Amph administration led
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Fig. 2. The eﬀect of pre-training and/or pre-test
amphetamine (Amph) treatment on the plus-maze
discriminative avoidance task in the test performance.
Mice were treated with saline (Sal) or 3 mg/kg Amph
15 min before the training session. After 24 h, the mice
were injected with Sal or 3 mg/kg Amph 15 min before the
testing. Results are presented as means¡S.E. of time (s)
spent in the non-aversive and in the aversive enclosed
arms (a), percent time spent in the aversive enclosed arm
(b) and percent time spent in the aversive enclosed arm
minute-by-minute throughout the test session (c). a p<0.05
compared to the time spent in the non-aversive enclosed
am within the group; b p<0.05 compared to the time
spent in the non-aversive enclosed arm of the other
groups ; c p<0.05 compared to the time spent in the
aversive enclosed arm of the other groups ; d p<0.05
compared to the time spent in the non-aversive enclosed
arm of the Sal–Sal group; e p<0.05 compared to the time
spent in the non-aversive enclosed arm of the Sal–Amph
and the Amph–Amph groups [three-way analysis of
variance (ANOVA) and Duncan’s test] ; *p<0.05
compared to all the other groups (two-way ANOVA and
Duncan’s test).
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to a decreased percent time spent in the open arms
during the training session (Fig. 3a). Quantifying this
parameter provides an eﬀective measure of anxiety
levels, as it is decreased by classic anxiogenic drugs,
such as caﬀeine (Silva & Frussa-Filho, 2000), and is
increased by classic anxiolytic agents, such as chlor-
diazepoxide and ethanol (Gulick & Gould, 2009a, b,
2011 ; Kameda et al. 2007; Silva & Frussa-Filho, 2000,
2002). In this vein, the anxiogenic eﬀect of Amph has
been extensively demonstrated with mice and rats,
both in the traditional elevated plus-maze (Biala &
Kruk, 2009 ; Biala et al. 2009; Lapin, 1993) and in the
PM-DAT (Silva et al. 2002a).
In the present study, the pre-training acute admin-
istration of 3 mg/kg Amph did not modify locomotor
activity (as measured by the total number of entries
into any of the arms) during the training session
(Fig. 3b). This result contradicts ﬁndings from our own
laboratory showing that a similar dose of Amph sig-
niﬁcantly enhanced the mouse’s locomotor activity in
the open-ﬁeld test (Calzavara et al. 2008; Carvalho et al.
2009). This discrepancy between the PM-DAT and
open-ﬁeld tests might suggest that measuring the
total number of entries in the former test may not be
a suﬃciently sensitive index of locomotor activity.
However, this seems not to be the case because
the total number of entries in the PM-DAT has
been shown to be as sensitive as the open-ﬁeld
model in evaluating hypolocomotion induced by the
catecholamine-depleting agent reserpine (Carvalho
et al. 2003; Silva et al. 2002b), as well as the classic
biphasic pattern of ethanol-derived changes in motor
activity (Araujo et al. 2005, 2006, 2009; Gulick & Gould,
2009a, b, 2011 ; Kameda et al. 2007). In addition, we
previously demonstrated that hyperlocomotion
induced by non-pharmacological methods such as
continuous exposure to light (Abı´lio et al. 1999) or
paradoxical sleep deprivation (Frussa-Filho et al. 2004)
can be accurately detected by the total number of
entries in the PM-DAT (Patti et al. 2010).
An alternative explanation for the discrepancy be-
tween the PM-DAT and open-ﬁeld test ﬁndings with
regard to Amph’s eﬀect on motor activity may lie in
the experimental design, as there are qualitative en-
vironmental diﬀerences between these two tests.
Indeed, whereas the open-ﬁeld arena can be a neutral
environment, the PM-DAT contains two open arms
simulating a condition naturally avoided by rodents
and one aversive enclosed arm that can be actively
avoided, making this apparatus more anxiogenic than
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an open-ﬁeld arena. This fact is supported by recent
reports that brightly illuminating (thereby making
more aversive) the open-ﬁeld arena decreases both
spontaneous (Bouwknecht et al. 2007) and Amph-
induced (Fukushiro & Frussa-Filho, 2010) locomotor
activity. Thus, the apparent absence of a hyperloco-
motor eﬀect of Amph in the PM-DAT could be ex-
plained by increased anxiety-like behaviour induced
by the drug combined with an aversive environment.
Within this context, our group has demonstrated that
the anxiogenic eﬀect of acute Amph administration
can mask its hyperlocomotor eﬀect (Zanlorenci et al.
unpublished data). Indeed, when Amph was admin-
istrated together with the anxiolytic benzodiazepine
chlordiazepoxide, the latter inhibited Amph-induced
anxiogenic eﬀects and enhanced Amph-induced
hyperlocomotor eﬀects in mice subjected to the open-
ﬁeld arena. Additionally, we demonstrated that the
PM-DAT was not sensitive enough to detect the well-
known stimulant eﬀect of caﬀeine unless chlordia-
zepoxide was also administered (Silva & Frussa-Filho,
2000).
Using the PM-DAT, our group and others have
reported that impaired memory can be identiﬁed as
reduced avoidance of the aversive enclosed arm in the
test session (Fig. 2a), namely, when the time spent in
this arm is the same as that spent in the non-aversive
enclosed arm. A similar eﬀect has been reported for
the pre-training administration of scopolamine (Claro
et al. 1999; Silva et al. 1999), chlordiazepoxide (Silva &
Frussa-Filho, 2000), morphine (Patti et al. 2006), etha-
nol (Gulick & Gould, 2009a, b, 2011 ; Kameda et al.
2007) and cocaine (Niigaki et al. 2010). Alternatively,
impaired memory can be demonstrated by an increase
in the percent time spent in the aversive enclosed
arm in the test session, even under conditions in which
the animal is able to avoid this arm. This eﬀect
has been reported for pre-training administration
of caﬀeine (Silva & Frussa-Filho, 2000) and Amph
(Silva et al. 2002a), and for paradoxical sleep depri-
vation (Alvarenga et al. 2008). In this regard, our
study corroborates the ﬁndings of Silva et al. (2002a),
who reported that the pre-training acute adminis-
tration of 1 or 3 mg/kg Amph induced amnestic ef-
fects seen as an increase in the percent time spent in the
aversive enclosed arm during the test session (Fig. 2b).
As mentioned in the Introduction, Amph can pro-
duce memory enhancement (Roozendaal et al. 1996;
Ventulani et al. 1993) dependent on the time of ad-
ministration (i.e. before or after the task training). In
this context, the cognitive eﬀect observed in the test
session could have been produced by a deleterious
eﬀect of Amph on memory or by a facilitatory eﬀect of
learning that the entry in the aversive arm is no longer
followed by the presentation of aversive stimuli. In the
present study, we have veriﬁed that all the groups
spent similar percent time in the aversive enclosed
arm throughout the test session (Fig. 2c), demonstrat-
ing that there were no alterations in their exploratory
pattern, thus discarding the possible occurrence of a
new learning in the test session.
Given the close relationship between memory and
anxiety in behavioural tasks (Mathews, 1990; Silva &
Frussa-Filho, 2000), the anxiogenic eﬀect of Amph
demonstrated in this study may have contributed to
the appearance of the Amph-induced retention deﬁcit
in the Amph–Sal group during the test session. In
support of this scenario, Silva & Frussa-Filho (2000)
demonstrated that altered (either increased or de-
creased) anxiety levels during the plus-maze dis-
criminative avoidance conditioning test led to
retention deﬁcits during testing. In that study, pre-
training caﬀeine administration decreased the per-
centage of time spent in the open arms in the training
session but did not modify acquisition performance.
Pre-training caﬀeine treatment did, however, lead to
performance deﬁcits during the test session that were
rescued by simultaneous pre-training chlordiazep-
oxide administration, as with the anxiogenic eﬀect. In
addition, the biochemical events involved in memory
formation are regulated by hormonal and neurohu-
moral mechanisms related to stress and anxiety
(Korneyev, 1997). Within this context, one could argue
that the cognitive eﬀects of Amph are derived from
the alterations in anxiety levels instead of being
mnemonic in nature. However, this does not seem
to be the case since we have demonstrated in a pre-
vious series of experiments (Silva et al. 2002a) that
the acute pre-training administration of 1 mg/kg
Amph also induced amnesia (likewise the adminis-
tration of 3 mg/kg) in the PM-DAT, without altering
anxiety or locomotion. Still in this concern, when
we administered 3 mg/kg for 10 consecutive days
before the training session in the same model, the
anxiogenic eﬀect was tolerated, but the memory deﬁcit
remained.
The amnestic eﬀect produced by pre-training
Amph administration (in the Amph–Sal group) was
completely abolished by pre-test Amph administration
(in the Amph–Amph group) and this result suggests a
preponderant involvement of the state-dependency
phenomenon on memory impairment induced by the
pre-training Amph administration (Fig. 2b).
State-dependent learning is often considered to
be bidirectional. Thus, animals that are trained after
a Sal injection should develop retention deﬁcits
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when Amph is administered before the test session.
However, in our study, mice given pre-training Sal
and pre-testing Amph (the Sal–Amph group) showed
retention levels similar to the control (Sal–Sal) group.
In this respect, it has been shown that drug-to-vehicle
changes often exert greater state-dependent eﬀects
then vehicle-to-drug changes (Colpaert, 1990 ; Jackson
et al. 1992; Patti et al. 2006).
From a clinical perspective, as recently noted
by Young & Colpaert (2009), the state-dependency of
stimulants such as Amph may dramatically inﬂuence
drug use, learning permanence and the ability to
use information in new conditions. According to
the authors, individuals who use Amph to enhance
learning may indeed learn slightly faster and/or
with less eﬀort than those who do not use Amph.
Later, however, they may need to retake Amph to re-
call or use the learned information. Our experimental
data seem in excellent agreement with this view. In
addition, state-dependency has been linked to both
anxiety and drug dependence in humans (Colpaert,
1990).
Taken together, these results corroborate our pre-
vious work (Silva et al. 2002a) describing decreased re-
tention of a discriminative avoidance task induced by
acute pre-training Amph administration. Importantly,
the present study demonstrates that this memory im-
pairment is state-dependent. These ﬁndings reinforce
the importance of considering the participation of
state-dependent learning when interpreting the cogni-
tive eﬀects of Amph.
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